How proteases regulate bone morphogenesis

被引:159
作者
Ortega, N [1 ]
Behonick, D [1 ]
Stickens, D [1 ]
Werb, Z [1 ]
机构
[1] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
来源
TISSUE REMODELING | 2003年 / 995卷
关键词
matrix metalloproteinases; endochondral ossification; angiogenesis; VEGF; MMP9;
D O I
10.1111/j.1749-6632.2003.tb03214.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Matrix metalloproteinases (MMPs) degrade most components of the extracellular matrix (ECM), as well as many non-ECM molecules. MMPs participate in (1) degradation of ECM to allow cell migration; (2) alteration of the ECM microenvironment resulting in alteration in cellular behavior; (3) modulation of biologically active molecules by direct cleavage or release from ECM stores; (4) regulation of the activity of other proteases; and (5) cell attachment, proliferation, differentiation, and apoptosis. We have sought to understand the role of MMPs during development and tissue repair in transgenic mice. Endochondral bone formation presents a particularly interesting developmental challenge. During this process, an avascular tissue (cartilage) is converted into one of the most highly vascularized tissues (bone) in the vertebrate body. Ossification begins with invasion of the calcified hypertrophic cartilage by capillaries. Apoptosis of the terminal hypertrophic chondrocytes, degradation of the cartilage matrix, and deposition of bone matrix by osteoblasts accompanies neovascularization of the growth plate. Remodeling of ECM results in a cavity filled with vascular channels containing hematopoietic cells. Our results reveal that MMP9, MMP13, and vascular endothelial growth factor are key regulators for the remodeling of the skeletal tissues. They coordinate not only matrix degradation, but also the recruitment and differentiation of endothelial cells, osteoclasts, chondroclasts, and osteoprogenitors.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 20 条
[1]
Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[2]
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[3]
Timeline - Matrix metalloproteinases: a tail of a frog that became a prince [J].
Brinckerhoff, CE ;
Matrisian, LM .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (03) :207-214
[4]
The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis [J].
Chang, C ;
Werb, Z .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S37-S43
[5]
New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[6]
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones [J].
Engsig, MT ;
Chen, QJ ;
Vu, TH ;
Pedersen, AC ;
Therkidsen, B ;
Lund, LR ;
Henriksen, K ;
Lenhard, T ;
Foged, NT ;
Werb, Z ;
Delaisse, JM .
JOURNAL OF CELL BIOLOGY, 2000, 151 (04) :879-889
[7]
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation [J].
Gerber, HP ;
Vu, TH ;
Ryan, AM ;
Kowalski, J ;
Werb, Z ;
Ferrara, N .
NATURE MEDICINE, 1999, 5 (06) :623-628
[8]
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment [J].
Hattori, K ;
Heissig, B ;
Wu, Y ;
Dias, S ;
Tejada, R ;
Ferris, B ;
Hicklin, DJ ;
Zhu, ZP ;
Bohlen, P ;
Witte, L ;
Hendrikx, J ;
Hackett, NR ;
Crystal, RG ;
Moore, MAS ;
Werb, Z ;
Lyden, D ;
Rafii, S .
NATURE MEDICINE, 2002, 8 (08) :841-849
[9]
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand [J].
Heissig, B ;
Hattori, K ;
Dias, S ;
Friedrich, M ;
Ferris, B ;
Hackett, NR ;
Crystal, RG ;
Besmer, P ;
Lyden, D ;
Moore, MAS ;
Werb, Z ;
Rafii, S .
CELL, 2002, 109 (05) :625-637
[10]
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover [J].
Holmbeck, K ;
Bianco, P ;
Caterina, J ;
Yamada, S ;
Kromer, M ;
Kuznetsov, SA ;
Mankani, M ;
Robey, PG ;
Poole, AR ;
Pidoux, I ;
Ward, JM ;
Birkedal-Hansen, H .
CELL, 1999, 99 (01) :81-92